Proposed new US funding rules: We can cancel any grant at any time
The Trump administration has moved to institutionalise substantial changes to how the federal government allocates research funding, submitting proposed rules through formal federal rulemaking channels that would fundamentally restructure the grant approval process. Rather than allowing peer-reviewed scientific merit to serve as the primary determinant of funding decisions, the new framework would empower political appointees to exercise final decision-making authority, explicitly instructing them not to "routinely defer" to scientific experts and peer reviewers who have traditionally shaped research priorities. Most significantly, the proposed rules would grant federal agencies the authority to terminate any grant at any time, provided officials can justify the cancellation through the nebulous standard that the project fails to serve the "national interest." This restructuring represents a deliberate departure from decades of established protocol that has positioned the United States as a global leader in scientific advancement and discovery. The shift from merit-based scientific evaluation to politically influenced allocation mechanisms constitutes the most consequential alteration to federal research funding architecture in generations, with implications extending far beyond individual grant decisions to reshape the entire ecosystem in which American science operates. The existing grant distribution system emerged from post-World War II recognition that scientific progress required insulation from short-term political fluctuations and ideological considerations. The peer review process, refined over decades, established mechanisms whereby scientists with recognised expertise in specific fields evaluated research proposals based on methodological soundness, feasibility, originality, and potential impact. Subject-matter experts employed by federal agencies such as the National Institutes of Health, National Science Foundation, and Department of Energy then utilised these evaluations to allocate limited resources with reasonable confidence that funded research would advance human knowledge efficiently. This separation between scientific evaluation and political direction proved instrumental in generating the discoveries, technologies, and institutional capacity that sustained American technological leadership throughout the latter twentieth century.
The Trump administration's executive order last August sought to overturn this arrangement, but initial legal challenges succeeded in vacating similar directives because they lacked adequate statutory justification. By channeling these objectives through formal rulemaking procedures rather than executive orders alone, administration officials aim to create regulatory precedent that withstands judicial scrutiny and establishes durable authority for political appointees to override scientific consensus in funding decisions. This manoeuvre represents a calculated escalation from previous attempts, designed to cement institutional changes that might otherwise prove legally vulnerable. The proposed rules introduce several mechanisms that extend far beyond mere alterations to the review hierarchy. The framework explicitly permits agencies to revoke existing grants at any point in their funding cycle should administrators determine that continued support fails to align with National Interest standards, a formulation so vague that it provides minimal constraint on bureaucratic discretion. The rules further enumerate specific subject areas where funding would face categorical restrictions, invoking what the administration characterises as cultural concerns but which critics identify as ideological gatekeeping. International research collaborations would encounter new barriers, a development particularly significant given that American scientific institutions have increasingly relied on international partnerships to address complex problems from pandemic response to climate science. Administrative expenses for scholarly communication activities, including publication fees and conference attendance, would face restrictions, effectively reducing researchers' ability to disseminate findings and engage with professional communities.
These provisions collectively indicate that the administration intends not merely to adjust priorities within existing research agendas but to exercise control over research directions, collaborative structures, and the mechanisms through which scientific knowledge circulates globally. For researchers and institutions dependent on federal funding, these changes present immediate and material consequences that extend beyond symbolic concerns about scientific autonomy. Universities and research hospitals derive substantial portions of operational budgets from federal grants, particularly those awarded through the National Institutes of Health, which distributes approximately 32 billion dollars annually in research funding. Retroactive grant termination authority creates profound budget uncertainty for institutions that have hired personnel, purchased equipment, and committed infrastructure to funded projects based on multi-year award expectations. The restrictions on international collaboration directly threaten research programs that have integrated colleagues from partner institutions, potentially forcing American researchers to choose between federal funding and participation in global research networks. The prohibition on conference attendance and publication expenses undermines the dissemination function essential to scientific progress, as researchers require venues to present preliminary findings, receive expert feedback, and remain current with developments in their fields. Small and mid-sized institutions, which often lack alternative funding sources available to elite research universities with substantial endowments, face particularly acute vulnerability to funding disruptions. These practical considerations create incentive structures that discourage researchers from pursuing questions that might be characterised as politically sensitive or that require international partnerships, effectively constraining the research agenda through mechanism that appears procedural but functions as content-based control.
The proposed rulemaking reflects and accelerates a broader erosion of institutional separation between political authority and expert judgment that extends across multiple policy domains but manifests with particular clarity in scientific governance. Federal agencies developed peer review mechanisms precisely because elected officials and political appointees lack the specialised knowledge required to evaluate complex scientific claims, methodologies, and feasibility assessments. Transferring final decision authority to politically appointed officials inverts this logic, substituting ideological alignment or political calculation for expertise-based evaluation. This pattern aligns with similar efforts to subordinate scientific and technical judgment to political preferences across regulatory agencies, from environmental protection to public health. The cumulative effect of such changes establishes precedent for treating scientific determinations as matters amenable to political override, fundamentally challenging the epistemic foundations upon which institutions like the National Academy of Sciences and the peer review system itself were constructed. International scientific communities have responded with concern about American capacity to maintain research leadership if institutional structures that enable rigorous, merit-based science give way to politically contingent arrangements. The implications extend beyond funding allocation to affect how American scientific institutions function internally, how research questions get framed, and ultimately which problems researchers can safely investigate without risking funding termination based on political calculation rather than scientific evaluation. Stakeholders should monitor closely the Office of Management and Budget's formal rulemaking timeline, which will determine when these provisions might acquire binding regulatory status and trigger implementation across federal agencies.
Congressional responses to the proposed rules will prove critical, particularly actions by members of both parties who represent districts with significant research institutions and university populations who may object to funding destabilisation. The National Institutes of Health and National Science Foundation will likely face the most immediate pressure to implement these requirements should rules move toward finalisation, creating urgent need for monitoring how these agencies interpret and execute politically appointed decision-making authority. Universities and research institutions should prepare scenario plans addressing potential grant termination and prepare advocacy positions regarding international collaboration restrictions. Scientific societies, including the National Academy of Sciences and discipline-specific professional organisations, will determine whether and how forcefully they contest institutional changes to peer review authority. Observers should anticipate significant litigation once rules are finalised, as legal challenges focusing on arbitrary and capricious agency action and due process concerns will likely emerge from universities and scientific organisations. The outcome of these proceedings will establish whether the federal government maintains mechanisms insulating scientific evaluation from short-term political influence or transitions toward systems where political appointees exercise substantial discretionary authority over research priorities and funding continuity.
